Skip to main content
Guangdong Transtek Medical Electronics Co.,Ltd logo

Guangdong Transtek Medical Electronics Co.,Ltd — Investor Relations & Filings

Ticker · 300562 ISIN · CNE100002DJ6 LEI · 836800C9I39HMUI8FF67 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,658 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300562

About Guangdong Transtek Medical Electronics Co.,Ltd

https://www.lifesense.com

Guangdong Transtek Medical Electronics Co.,Ltd. specializes in the research, development, and manufacturing of smart healthcare and medical electronic devices. The company provides comprehensive solutions for remote patient monitoring and chronic disease management through an integrated ecosystem of hardware and software. Its core product portfolio includes digital blood pressure monitors, smart body fat scales, wearable fitness trackers, and medical-grade hearing aids. Transtek operates primarily as a global OEM and ODM partner, leveraging advanced IoT technology to connect medical devices with cloud-based health platforms. By focusing on data accuracy and connectivity, the company supports healthcare providers and consumer brands in delivering personalized health insights. Its manufacturing facilities adhere to international quality standards, including FDA and CE certifications, ensuring high-precision diagnostic tools for global markets.

Recent filings

Filing Released Lang Actions
关于获得医疗器械注册证的公告
Regulatory Filings Classification · 87% confidence This document is an official announcement by Guangdong Lifesense Medical Electronic Co., Ltd. regarding the approval and issuance of a medical device registration certificate. It is not a financial report, earnings release, board change, or any other specific category. It’s a general regulatory/compliance announcement conveying new certificate approval, which falls under Regulatory Filings (RNS) as a miscellaneous compliance update.
2026-05-29 Chinese
关于使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 87% confidence The document is a formal corporate announcement by Guangdong LifeSense Medical Electronics Co., Ltd. detailing the company’s use of idle fundraising proceeds for short-term cash management products, including amounts, products, dates, approvals, risk controls, and past transactions. It does not present financial statements, earnings results, or legal proceedings, nor is it a call transcript or dividend notice. It specifically reports on financing activities—namely, the use of raised capital for cash management. Therefore, it falls under the Capital/Financing Update category (CAP).
2026-05-29 Chinese
关于申报医疗器械注册证获得受理的公告
Regulatory Filings Classification · 85% confidence The document is a company announcement disclosing that the FDA has accepted its medical device registration application. It contains no financial results, board changes, or substantive financial data—it is a compliance/regulatory update. This falls under the general “Regulatory Filings” category as a regulatory announcement that does not fit any other specific filing type.
2026-05-20 Chinese
关于重新签订募集资金三方监管协议的公告
Capital/Financing Update Classification · 85% confidence The document is an official Chinese A-share announcement by Guangdong Lifesense Medical Electronics Co., Ltd. regarding the re-signing of the tripartite supervision agreement for previously raised funds (“募集资金三方监管协议”). It details the original fundraise, amounts raised, use of proceeds, and terms of the new supervision agreement with a bank and sponsor. There is no new share issue or dividend declaration; rather, it is a management update on the company’s fundraising use and oversight. This matches the Capital/Financing Update category.
2026-05-19 Chinese
北京国枫（深圳）律师事务所关于广东乐心医疗电子股份有限公司2026年第一次临时股东会的法律意见书
Regulatory Filings Classification · 93% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and voting results of an extraordinary shareholders’ meeting, it does not itself constitute a financial or annual report, nor is it a notice of report publication. It is essentially an attestation of legal compliance under securities laws, fitting the ‘Regulatory Filings’ fallback for certifications and compliance opinions (RNS).
2026-05-14 Chinese
2026年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions and voting results from the 2026 first extraordinary shareholders’ meeting of Guangdong Lifesense Medical Electronics Co., Ltd. It details the meeting attendance, ballot counts, and approval outcomes for a specific proposal. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (Code: DVA), which covers official vote results from shareholder meetings.
2026-05-14 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.